Zusammensetzung information
Zusammensetzung, Synonyme
- Loncastuximabum tesirinum
- Loncastuximab tesirine
- Loncastuximab tesirina
- Immunoglobulin G1-kappa, anti-[Homo sapiens CD19 (B lymphocyte surface antigen B4, Leu-12)], chimeric monoclonal antibody conjugated to the pyrrolobenzodiazepine (PBD) dimer SCX; gamma1 heavy chain (1-449) [Mus musculus VH (IGHV1-69*02 (85.70%)-(IGHD)-IGHJ4*01) [8.8.13] (1-120)-Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 (CH1 R120>K (217) (121-218), hinge (219-233), CH2 (234-343), CH3 E12 (359), M14 (361) (344-448), CHS K2>del (449)) (121-449)], (223-211 )-disulfide with kappa light chain (1 -211
- Loncastuximab tesirin
Andere Arzneimittel
Bezeichnung | PZN | Form | Verpackung | Hersteller | Preis | |
---|---|---|---|---|---|---|
Details | ZYNLONTA 10 mg Plv.f.e.Konz.z.Her.e.Inf.-Lsg.Dsfl. | P18423652 | PKI | 1 St | SWEDI | € 7688.02 |